Supplemental material
Current Medical Research and Opinion
Volume 39, 2023 - Issue 2
Hematology
Comprehensive analysis and prediction of long-term durability of factor IX activity following etranacogene dezaparvovec gene therapy in the treatment of hemophilia B
Jinesh ShahCSL Behring, King of Prussia, PA, USACorrespondence[email protected]
https://orcid.org/0000-0002-6594-8041
https://orcid.org/0000-0002-6594-8041, Hongseok KimCSL Behring, King of Prussia, PA, USAhttps://orcid.org/0000-0003-1964-4749
https://orcid.org/0000-0003-1964-4749, Krupa SivamurthyCSL Behring, King of Prussia, PA, USAhttps://orcid.org/0000-0002-0487-3111
https://orcid.org/0000-0002-0487-3111, Paul E. MonahanCSL Behring, King of Prussia, PA, USAhttps://orcid.org/0000-0003-2110-0740
https://orcid.org/0000-0003-2110-0740 & Michael FriesCSL Behring, King of Prussia, PA, USAhttps://orcid.org/0000-0002-3958-8775
https://orcid.org/0000-0002-3958-8775